| Brown Nursing Home | |
| 2334 Washington Street, Alexander City, Alabama 35010 | |
| (256) 329-9061 | |
| Name | Brown Nursing Home |
|---|---|
| Location | 2334 Washington Street, Alexander City, Alabama |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 68 |
| Occupancy Rate | 91.32% |
| Medicare ID (CCN) | 015191 |
| Legal Business Name | Brown Nursing Home, Llc |
| Ownership Type | For Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The arsenal of prostate cancer treatments for men with advanced prostate cancer may soon be strengthened as the FDA prioritizes the review of both Ra-223 and MDV3100 for treating metastatic castration-resistant prostate cancer (CRPC). Based on positive, independent research of each drug, better survival rates and improved bone health for patients with late-stage prostate cancer may be within reach.
VisionCare, Inc. ("VisionCare"), a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced the U.S. Food and Drug Administration (FDA) approved the company's investigational device exemption for a new U.S. clinical study.
Cancer immunology is all about how your immune cells are going to fight and kill your tumor cells. If you look at the pure genetic code of a T-cell that's going to kill your tumor compared to the same cell that has been "put-to-sleep" (by the tumor), the pure genetic DNA content of those two cells are identical.
The state appealed to the federal government yesterday to help Massachusetts hospitals that care for disproportionately high numbers of lower-income patients who receive state-sponsored health insurance. Governor Deval Patrick is asking the Obama administration for $216 million for Cambridge Health Alliance, the state's only public acute-care hospital, and another $115 million for six private hospitals with high Medicaid patient populations
Kent L. Klaudt, a partner in the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that James Cabral today filed a personal injury lawsuit against Zimmer Inc., the nation's largest producer of orthopedic devices. Cabral has suffered constant and devastating pain for over 18 months and will have to undergo a second hip replacement surgery due to an allegedly defective hip implant manufactured and sold by Zimmer under the brand name Durom Cup.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 8.78 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.76 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 57.01 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.06 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.64 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.37 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.73 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 27.52 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.56 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.05 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 0 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.55 | 82.93 |
News Archive
The arsenal of prostate cancer treatments for men with advanced prostate cancer may soon be strengthened as the FDA prioritizes the review of both Ra-223 and MDV3100 for treating metastatic castration-resistant prostate cancer (CRPC). Based on positive, independent research of each drug, better survival rates and improved bone health for patients with late-stage prostate cancer may be within reach.
VisionCare, Inc. ("VisionCare"), a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced the U.S. Food and Drug Administration (FDA) approved the company's investigational device exemption for a new U.S. clinical study.
Cancer immunology is all about how your immune cells are going to fight and kill your tumor cells. If you look at the pure genetic code of a T-cell that's going to kill your tumor compared to the same cell that has been "put-to-sleep" (by the tumor), the pure genetic DNA content of those two cells are identical.
The state appealed to the federal government yesterday to help Massachusetts hospitals that care for disproportionately high numbers of lower-income patients who receive state-sponsored health insurance. Governor Deval Patrick is asking the Obama administration for $216 million for Cambridge Health Alliance, the state's only public acute-care hospital, and another $115 million for six private hospitals with high Medicaid patient populations
Kent L. Klaudt, a partner in the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that James Cabral today filed a personal injury lawsuit against Zimmer Inc., the nation's largest producer of orthopedic devices. Cabral has suffered constant and devastating pain for over 18 months and will have to undergo a second hip replacement surgery due to an allegedly defective hip implant manufactured and sold by Zimmer under the brand name Durom Cup.
› Verified 1 days ago
Brown Nursing Home Location: 2334 Washington Street, Alexander City, Alabama 35010 Phone: (256) 329-9061 | |
Chapman Healthcare Center, Inc Location: 3701 Dadeville Road, Alexander City, Alabama 35010 Phone: (256) 234-6366 | |
Adams Nursing Home Location: 1555 Hillabee Street, Alexander City, Alabama 35010 Phone: (256) 329-0847 |